中华现代护理杂志
中華現代護理雜誌
중화현대호리잡지
CHINESE JOURNAL OF MODERN NURSING
2013年
26期
3274-3277
,共4页
庄细琴%朱滨%丁良才%王大明%缪立英
莊細琴%硃濱%丁良纔%王大明%繆立英
장세금%주빈%정량재%왕대명%무립영
护理%全身炎症反应综合征%血液滤过%吸附解毒
護理%全身炎癥反應綜閤徵%血液濾過%吸附解毒
호리%전신염증반응종합정%혈액려과%흡부해독
Nursing%Systemic inflammatory response syndrome%Hemofiltration%Absorption
目的 探讨全身炎症反应综合征(SIRS)患者进行全血吸附(AP)并联连续性静脉-静脉血液滤过(CVVH)清除血清炎症介质的效果和护理要点.方法 将63例SIRS患者随机分为治疗组(AP并联CVVH方法)31例和对照组(单纯CVVH方法)32例,记录患者治疗前后血清炎症介质(TNF、CRP、IL-1、IL-6和IL-10)数值并进行组内和组间统计学比较.结果 两组患者治疗前TNF、CRP、IL-1、IL-6、IL-10比较差异无统计学意义(P>0.05).治疗后2,26,50h治疗组TNF、CRP、IL-1、IL-6和IL-10水平呈下降趋势,与治疗前比较差异均有统计学意义(P<0.05).治疗后2,26,50 h对照组TNF、CRP、IL-1、IL-6和IL-10水平呈下降趋势,与治疗前比较,治疗后2h差异无统计学意义(P>0.05),治疗后26,50 h差异有统计学意义(P<0.05).治疗后相同时间点治疗组与对照组TNF、CRP、IL-1、IL-6和IL-10水平比较差异有统计学意义(P<0.05),如TNF,治疗后2,26,50h治疗组分别为(226.4 ±27.6),(165.3±24.5),(120.6±19.2)ng/L,对照组分别为(315.7±38.3),(262.7±29.4),(219.3±25.6) ng/L,差异均有统计学意义(t值分别为-3.31,-7.19,-8.79;P <0.05).结论 AP并联CVVH能有效清除SIRS患者血清中的炎症介质.护理人员的严密监测和护理是治疗顺利进行并达到预期目标的重要环节.
目的 探討全身炎癥反應綜閤徵(SIRS)患者進行全血吸附(AP)併聯連續性靜脈-靜脈血液濾過(CVVH)清除血清炎癥介質的效果和護理要點.方法 將63例SIRS患者隨機分為治療組(AP併聯CVVH方法)31例和對照組(單純CVVH方法)32例,記錄患者治療前後血清炎癥介質(TNF、CRP、IL-1、IL-6和IL-10)數值併進行組內和組間統計學比較.結果 兩組患者治療前TNF、CRP、IL-1、IL-6、IL-10比較差異無統計學意義(P>0.05).治療後2,26,50h治療組TNF、CRP、IL-1、IL-6和IL-10水平呈下降趨勢,與治療前比較差異均有統計學意義(P<0.05).治療後2,26,50 h對照組TNF、CRP、IL-1、IL-6和IL-10水平呈下降趨勢,與治療前比較,治療後2h差異無統計學意義(P>0.05),治療後26,50 h差異有統計學意義(P<0.05).治療後相同時間點治療組與對照組TNF、CRP、IL-1、IL-6和IL-10水平比較差異有統計學意義(P<0.05),如TNF,治療後2,26,50h治療組分彆為(226.4 ±27.6),(165.3±24.5),(120.6±19.2)ng/L,對照組分彆為(315.7±38.3),(262.7±29.4),(219.3±25.6) ng/L,差異均有統計學意義(t值分彆為-3.31,-7.19,-8.79;P <0.05).結論 AP併聯CVVH能有效清除SIRS患者血清中的炎癥介質.護理人員的嚴密鑑測和護理是治療順利進行併達到預期目標的重要環節.
목적 탐토전신염증반응종합정(SIRS)환자진행전혈흡부(AP)병련련속성정맥-정맥혈액려과(CVVH)청제혈청염증개질적효과화호리요점.방법 장63례SIRS환자수궤분위치료조(AP병련CVVH방법)31례화대조조(단순CVVH방법)32례,기록환자치료전후혈청염증개질(TNF、CRP、IL-1、IL-6화IL-10)수치병진행조내화조간통계학비교.결과 량조환자치료전TNF、CRP、IL-1、IL-6、IL-10비교차이무통계학의의(P>0.05).치료후2,26,50h치료조TNF、CRP、IL-1、IL-6화IL-10수평정하강추세,여치료전비교차이균유통계학의의(P<0.05).치료후2,26,50 h대조조TNF、CRP、IL-1、IL-6화IL-10수평정하강추세,여치료전비교,치료후2h차이무통계학의의(P>0.05),치료후26,50 h차이유통계학의의(P<0.05).치료후상동시간점치료조여대조조TNF、CRP、IL-1、IL-6화IL-10수평비교차이유통계학의의(P<0.05),여TNF,치료후2,26,50h치료조분별위(226.4 ±27.6),(165.3±24.5),(120.6±19.2)ng/L,대조조분별위(315.7±38.3),(262.7±29.4),(219.3±25.6) ng/L,차이균유통계학의의(t치분별위-3.31,-7.19,-8.79;P <0.05).결론 AP병련CVVH능유효청제SIRS환자혈청중적염증개질.호리인원적엄밀감측화호리시치료순리진행병체도예기목표적중요배절.
Objective To discuss the effect of absorption (AP) combined with continuous venovenous hemofiltration (CVVH) on eliminating serum inflammatory medium for patients with systemic inflammatory response syndrome (SIRS) and its nursing essence.Methods Totals of 63 patients with SIRS were randomly divided into the treatment group (AP combined with CWH,n =31) and the control group (CWH,n =32).Data of serum inflammatory medium,such as TNF,CRP,IL-1,IL-6 and IL-10 were recorded and compared within and between two groups before and after the treatment.Results There was no statistically significant difference in TNF,CRP,IL-1,IL-6 and IL-10 between two groups before treatment (P > 0.05).After the treatment,levels of TNF,CRP,IL-1,IL-6 and IL-10 in 2,26 and 50 hours showed descending tendency in the treatment group,and the differences were statistically significant compared with before (P < 0.05).Levels of TNF,CRP,IL-1,IL-6 and IL-102,26 and 50 hours after the treatment in the control group also showed descending tendency,and the differences were statistically significant compared with before (P < 0.05) except data in 2 hours (P > 0.05).Levels of TNF,CRP,IL-1,IL-6 and IL-10 also had statistically significant differences between two groups at the same time (P < 0.05).For example,score of TNF was respectively (226.4±27.6),(165.3 ±24.5),(120.6 ± 19.2) ng/L 2,26 and 50 hours after treatment in the treatment group and (315.7 ± 38.3),(262.7 ± 29.4),(219.3 ± 25.6) ng/L in the control group,with statistically significant differences (t =-3.31,-7.19,-8.79,respectively; P < 0.05).Condusions AP combined with CVVH can effectively eliminate the serous inflammatory medium for SIRS patients,and close surveillance and nursing are key to smooth treatment and expectations achievement.